Effects of C-reactive protein on atherogenic mediators and adrenomedullin in human coronary artery endothelial and smooth muscle cells

Biochemical and Biophysical Research Communications

Volumn 314, Issue 4, 2004, Pages 1057-1063

  Nagoshi, Yasuko ^a   Kuwasako, Kenji ^a   Cao, Yuan Ning ^a   Kitamura, Kazuo ^a   Eto, Tanenao ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Adrenomedullin; Atherosclerosis; Coronary artery; Endotoxin; Interleukin 6; MCP 1; Recombinant CRP

Indexed keywords

ADRENOMEDULLIN; CALCIUM; ENDOTHELIN 1; ENDOTOXIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHORYLCHOLINE; RECOMBINANT C REACTIVE PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; ATHEROGENESIS; CALCIUM BINDING; CALCIUM CELL LEVEL; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; DRUG EFFECT; HEART MUSCLE CELL; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PURIFICATION; SMOOTH MUSCLE FIBER;

EID: 0942300662     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.01.004     Document Type: Article

References (34)

1. Volanakis J.E. Human C-reactive protein: expression, structure, and function. Mol. Immunol. 38:2001;189-197.
2. Ledue T.B., Rifai N. Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment. Clin. Chem. 49:2003;1258-1271.
3. Verma S., Li S.H., Badiwala M.V., Weisel R.D., Fedak P.W.M., Li R.K., Dhillon B., Mickle D.A.G. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation. 105:2002;1890-1896.
4. Pasceri V., Chang J., Willerson J.T., Yeh E.T.H. Modulation of C-reactive protein- mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation. 103:2001;2531-2534.
5. Devaraj S., Xu D.Y., Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherosclerosis. Circulation. 107:2003;398-404.
6. Verma S., Wang C.H., Li S.H., Dumont A.S., Fedak P.W.M., Badiwala M.V., Dhillon B., Weisel R.D., Li R.K., Mickle D.A.G., Stewart D.J. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation. 106:2002;913-919.
7. Wang C.H., Li S.H., Weisel R.D., Fedak P.W.M., Dumont A.S., Szmitko P., Li R.K., Mickle D.A.G., Verma S. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation. 107:2003;r53-r60.
8. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H., Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human Pheochromocytoma. Biochem. Biophys. Res. Commun. 192:1993;553-560.
9. 2+ mobilization, in bovine aortic endothelial cells. J. Biol. Chem. 270:1995;4412-4417.
10. Shimosawa T., Shibagaki Y., Ishibashi K., Kitamura K., Kangawa K., Kato S., Ando K., Fujita T. Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage. Circulation. 105:2002;106-111.
11. Shimosawa T., Ogihara T., Matsui H., Asano T., Ando K., Fujita T. Deficiency of adrenomedullin induces insulin resistance by increasing oxidative stress. Hypertension. 41:2003;1080-1085.
12. Heinecke J.W. Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis. Am. J. Cardiol. 91:2003;12A-16A.
13. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N., Solari R., Lee M.G., Foord S.M. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature. 393:1998;333-339.
14. Kuwasako K., Shimekake Y., Masuda M., Nakahara K., Yoshida T., Kitaura M., Kitamura K., Eto T., Sakata T. Visualization of the calcitonin receptor-like receptor and its receptor activity-modifying proteins during internalization and recycling. J. Biol. Chem. 275:2000;29602-29609.
15. Nagoshi Y., Kuwasako K., Ito K., Uemura T., Kato J., Kitamura K., Eto T. The calcitonin receptor-like receptor/receptor activity-modifying protein 1 heterodimer can function as a calcitonin gene-related peptide-(8-37)-sensitive adrenomedullin receptor. Eur. J. Pharmacol. 450:2002;237-243.
16. Aiyar N., Rand K., Elshourbagy N.A., Zeng Z., Adamou J.E., Bergsma D.J., Li Y. A cDNA encoding the calcitonin gene-related peptide type 1 receptor. J. Biol. Chem. 271:1996;11325-11329.
17. Tanaka T., Horio T., Matuo Y. Secretory production of recombinant human C- reactive protein in Escherichia coli, capable of binding with phosphorylcholine, and its characterization. Biochem. Biophys. Res. Commun. 295:2002;163-166.
18. Hirano T., Yasukawa K., Harada H., Taga T., Watanabe Y., Matsuda T., Kashiwamura S., Nakajima K., Koyama K., Iwamatsu A. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature. 324:1986;73-76.
19. Hosang K., Knoke I., Klaudiny J., Wempe F., Wuttke W., Scheit K.H. Procine luteal cells express monocyte chemoattractant protein-1 (MCP-1): analysis by polymerase chain reaction and cDNA cloning. Biochem. Biophys. Res. Commun. 199:1994;962-968.
20. Asakura H., Jokaji H., Saito M., Uotani C., Kumabashiri I., Morishita E., Yamazaki M., Matsuda T. Plasma levels of soluble thrombomodulin increase in cases of disseminated intravascular coagulation with organ failure. Am. J. Hematol. 38:1991;281-287.
21. Tanebe M., Teshima S., Hanyu T., Hayashi Y. Rapid and sensitive method for erythropoietin determination in serum. Clin. Chem. 38:1992;1752-1755.
22. Kitamura K., Kato J., Kawamoto M., Tanaka M., Chino N., Kangawa K., Eto T. The intermediate form of glycine-extended adrenomedullin is the major circulating molecular form in human plasma. Biochem. Biophys. Res. Commun. 244:1998.
23. Weiner S.M., Prasauskas V., Lebrecht D., Weber S., Peter H.H., Vaith P. Occurrence of C-reactive protein in cryoglobulins. Clin. Exp. Immunol. 125:2001;316-322.
24. Lindmark E., Diderholm E., Wallentin L., Siegbahn A. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. JAMA. 286:2001;2107-2113.
25. Rus H.G., Vlaicu R., Niculescu F. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis. 127:1996;263-271.
26. Schieffer B., Schieffer E., Hilfiker-Kleiner D., Hifiker A., Kovanen P.T., Kaartinen M., Nussberger J., Harringer W., Drexler H. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation. 101:2000;1372-1378.
27. Ishikawa T., Hatakeyama K., Imamura T., Date H., Shibata Y., Hikichi Y., Asada Y., Eto T. Involvement of C-reactive protein obtained by directional coronary atherectomy in plaque instability and developing restenosis in patients with stable or unstable angina pectoris. Am. J. Cardiol. 91:2003;287-292.
28. Weinhold B., Ruther U. Interleukin-6-dependent and -independent regulation of the human C-reactive protein gene. Biochem. J. 327:1997;425-429.
29. Boring L., Gosling J., Cleary M., Charo I.F. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 394:1998;894-897.
30. Gu L., Okada Y., Clinton S.K., Gerard C., Sukhova G.K., Libby P., Rollins B.J. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell. 2:1998;275-281.
31. Sobel B.E. Increased PAI-1 and vasculopathy: a reconcilable paradox. Circulation. 99:1999;2496-2498.
32. Eren M., Painter C.A., Atkinson J.B., Declerck P.J., Vaughan D.E. Age-dependent spontaneous coronary arterial thrombosis in transgenic mice that express a stable form of human plasminogen activator inhibitor-1. Circulation. 106:2002;491-496.
33. Horio T., Kohno M., Kano H., Ikeda M., Yasunari K., Yokokawa K., Minami M., Takeda T. Adrenomedullin as a novel antimigration factor of vascular smooth muscle cells. Circ. Res. 77:1995;660-664.
34. Kano H., Kohno M., Yasunari K., Yokokawa K., Horio T., Ikeda M., Minami M., Hanehira T., Takeda T., Yoshikawa J. Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells. J. Hypertens. 14:1996;209-213.